Literature DB >> 7698699

Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis.

S J Mills1, N A Shepherd, P A Hall, A Hastings, J C Mathers, A Gunn.   

Abstract

Previous work has shown abnormalities in the proliferative activity of the colorectal mucosa in familial adenomatous polyposis (FAP). Some doubts remain about the validity of these findings because of difficulties in excluding adenomatous crypts, particularly in methods using tritiated thymidine, bromodeoxyuridine, and ornithine decarboxylase. The proliferative activity of the epithelium in colonic resections from 20 FAP patients was compared with that of age, sex, and site matched controls using a new monoclonal antibody MIB1 to assay the expression of Ki-67 antigen in routinely processed tissue. The labelling indices were very similar in the polyposis and control cases (25.5 (1.4)% and 26.7 (1.7)% respectively) but analysis of the distribution of labelled cells showed a significant shift of the proliferative compartment towards the luminal surface in the FAP group. Specifically, the labelling index was lower in the basal fifth of the polyposis crypts and higher in the two fifths at the luminal surface. These results show that analysis of proliferative activity in FAP is now achievable in routine histological material and indicate deregulation of proliferative control in the FAP colonic crypt. This may form a useful diagnostic adjunct to standard clinical and molecular genetic techniques, particularly in view of the current interest in dietary and pharmacological intervention in sporadic colorectal carcinoma.

Entities:  

Mesh:

Year:  1995        PMID: 7698699      PMCID: PMC1382452          DOI: 10.1136/gut.36.3.391

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  IN VITRO STUDY OF HUMAN RECTAL EPITHELIAL CELLS. I. ATYPICAL ZONE OF H3 THYMIDINE INCORPORATION IN MUCOSA OF MULTIPLE POLYPOSIS.

Authors:  E DESCHNER; C M LEWIS; M LIPKIN
Journal:  J Clin Invest       Date:  1963-12       Impact factor: 14.808

2.  Assignment of the human Ki-67 gene (MK167) to 10q25-qter.

Authors:  C Fonatsch; M Duchrow; H Rieder; C Schlüter; J Gerdes
Journal:  Genomics       Date:  1991-10       Impact factor: 5.736

3.  Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique.

Authors:  R A Goodlad; S Levi; C Y Lee; N Mandir; H Hodgson; N A Wright
Journal:  Gastroenterology       Date:  1991-11       Impact factor: 22.682

4.  A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction.

Authors:  R J Scott; P A Hall; J S Haldane; S van Noorden; Y Price; D P Lane; N A Wright
Journal:  J Pathol       Date:  1991-10       Impact factor: 7.996

Review 5.  Rectal cell proliferation as an intermediate biomarker of risk of colorectal cancer.

Authors:  G Biasco; G M Paganelli; G Brandi; R Santucci; M Renga; A Facchini; M Miglioli; L Barbara
Journal:  Eur J Cancer Prev       Date:  1993-06       Impact factor: 2.497

6.  The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens.

Authors:  D McCormick; C Yu; C Hobbs; P A Hall
Journal:  Histopathology       Date:  1993-06       Impact factor: 5.087

7.  Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer.

Authors:  S Nakamura; I Kino; S Baba
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

8.  Rectal cell proliferation and colorectal cancer risk level in patients with nonfamilial adenomatous polyps of the large bowel.

Authors:  G M Paganelli; G Biasco; R Santucci; G Brandi; A A Lalli; M Miglioli; L Barbara
Journal:  Cancer       Date:  1991-12-01       Impact factor: 6.860

9.  Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps.

Authors:  R J Cahill; K R O'Sullivan; P M Mathias; S Beattie; H Hamilton; C O'Morain
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

10.  Proliferation in human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for different sites, proximity to a tumour, and polyposis coli.

Authors:  C S Potten; M Kellett; D A Rew; S A Roberts
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

View more
  6 in total

1.  Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac.

Authors:  J J Keller; G J Offerhaus; M Polak; S N Goodman; M L Zahurak; L M Hylind; S R Hamilton; F M Giardiello
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

2.  Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer.

Authors:  S E Green; P Chapman; J Burn; A D Burt; M Bennett; D R Appleton; J S Varma; J C Mathers
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

3.  Colon Crypts of Subjects With Familial Adenomatous Polyposis Show an Increased Number of LGR5+ Ectopic Stem Cells.

Authors:  Lucas T Jennelle; Christopher H Dampier; Stephanie Tring; Steven Powell; Graham Casey
Journal:  Clin Transl Gastroenterol       Date:  2021-05-17       Impact factor: 4.396

4.  Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

Authors:  M A Hull; J K Booth; A Tisbury; N Scott; C Bonifer; A F Markham; P L Coletta
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

5.  Hepatocytes buried in the cirrhotic livers of patients with biliary atresia proliferate and function in the livers of urokinase-type plasminogen activator-NOG mice.

Authors:  Hiroshi Suemizu; Kazuaki Nakamura; Kenji Kawai; Yuichiro Higuchi; Mureo Kasahara; Junichiro Fujimoto; Akito Tanoue; Masato Nakamura
Journal:  Liver Transpl       Date:  2014-08-04       Impact factor: 5.799

Review 6.  An APC:WNT Counter-Current-Like Mechanism Regulates Cell Division Along the Human Colonic Crypt Axis: A Mechanism That Explains How APC Mutations Induce Proliferative Abnormalities That Drive Colon Cancer Development.

Authors:  Bruce M Boman; Jeremy Z Fields
Journal:  Front Oncol       Date:  2013-11-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.